Affiliation:
1. From the Department of Medicine, Division of Cardiology, The Ohio State University College of Medicine and the Department of Statistics, Columbus, Ohio.
Abstract
Controversy exists over the rapidity of onset of the inotropic effect of various digitalis glycosides. Shortening of the systolic time intervals (STI) provides a quantitative measure of the inotropic effect of digitalis glycosides in human subjects. Total electromechanical systole corrected for heart rate (QS
2
I) is the most sensitive of the STI since it combines the shortening effect of digitalis glycosides on both the pre-ejection period and ejection time. Normal volunteer subjects were studied serially following i.v. injection of 1.6 mg cedilanid-D (C) (n = 18), 1.0 mg ouabain (O) (n = 12), 1.6 mg digoxin (D) (n = 16), and 1.6 mg digitoxin (DT) (n = 9). The shortening of QS
2
I was corrected for the molecular weight of the digitalis glycoside. The onset of shortening of the QS
2
I/ mole proved to be exponential for each digitalis glycoside. This allowed estimation of the maximum shortening of QS
2
I/mole (A) which would occur assuming zero excretion, from which the time constant (t
c
) of the curves could be determined. There was no significant difference in A among the digitalis glycosides. The t
c
, were 5.8 min (O), 7.2 min (C), 23 min (D), and 56 min (DT). These t
c
were significantly different except for O and C. Thus both C and O have a rapid onset of activity which is significantly shorter than either D or DT. The t
c
for C in patients with congestive heart failure is the same as normals. This study provides a heretofore unavailable, accurate measure of the differences among commonly used glycosides.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Physiology (medical),Cardiology and Cardiovascular Medicine
Reference21 articles.
1. INTRAVENOUS INJECTION OF OUABAIN IN MAN
2. Physiological adaptations in cardiac slowing by digitalis and their bearing on problems of digitalization in patients with auricular fibrillation;J Pharm Exptl Ther,1939
3. com.atypon.pdfplus.internal.model.plusxml.impl.AuthorGroup@6bb0e9df ROSE 0 DEGRAFF A: The combined use of ouabain and digitalis in the treatment of congestive heart failure. Am Heart J 20: 443 1940
4. Studies on purified digitalis glycosides;J Pharm and Exptl Ther,1940
5. Clinical studies on digitoxin (digitaline nativelle);J Pharm Exptl Ther,1944
Cited by
68 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献